Clinical trial
Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities
NCT00311649 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00311649 |
|---|---|
| Title | Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities |
| Official title | Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Inactivated Influenza A Vaccine A/H5N1 |
| Enrollment | 83 |
| Start date | Nov 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Apr 6, 2006 |
| Last update posted | Aug 12, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: